Immediate coronary artery bypass surgery after platelet inhibition with eptifibatide: results from PURSUIT
- 1 September 2000
- journal article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 70 (3) , 866-871
- https://doi.org/10.1016/s0003-4975(00)01654-4
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Preoperative Use of Enoxaparin and Tirofiban: Possible Association with Increased Bleeding PostbypassAnesthesiology, 1999
- Complementary Clinical Benefits of Coronary-Artery Stenting and Blockade of Platelet Glycoprotein IIb/IIIa ReceptorsNew England Journal of Medicine, 1999
- Inhibition of Platelet Glycoprotein IIb/IIIa with Eptifibatide in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 1998
- Emergency coronary bypass grafting for failed percutaneous coronary artery stenting: increased costs and platelet transfusion requirements after the use of abciximabThe Journal of Thoracic and Cardiovascular Surgery, 1998
- Abciximab and Excessive Bleeding in Patients Undergoing Emergency Cardiac OperationsThe Annals of Thoracic Surgery, 1998
- Toward a New Frontier in Myocardial Reperfusion TherapyCirculation, 1998
- Platelet Glycoprotein IIb/IIIa Receptor Blockade and Low-Dose Heparin during Percutaneous Coronary RevascularizationNew England Journal of Medicine, 1997
- Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-IIThe Lancet, 1997
- Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary AngioplastyNew England Journal of Medicine, 1994
- Thrombosis in Unstable AnginaNew England Journal of Medicine, 1992